Globally recognised as a first-line standard of care, the public funding of ERBITUX® (cetuximab) [1] marks an important development for people living with left-sided RAS wild-type and BRAF wild-type ...

Globally recognised as a first-line standard of care, the public funding of ERBITUX®(cetuximab)[1] marks an important development for people living with left-sided RAS wild-type and BRAF wild ...

For example, RAS mutations activate signalling pathways that are downstream of the epidermal growth factor receptor (EGFR), rendering EGFR inhibitors such as cetuximab inactive. Second ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

After hours: October 18 at 7:12 PM EDT Loading Chart for ZNTL ...